@HypoResolve on Oct 12, 2020
Second Hypo-RESOLVE progress report
The Hypo-RESOLVE consortium is very pleased to announce that the EC accepted its 2nd progress report covering the achievements of the second year in Hypo-RESOLVE. During those twelve months, considera...
Hypo-RESOLVE featured in IMI’s newsroom
The Hypo-RESOLVE Consortium is pleased to communicate that on 24th September 2020 the IMI published The constant threat of 'hypos' takes a heavy toll on people with diabetes based on a Q&A interview...
Virtual Managing Board Meeting
On 21st September 2020, the Hypo-RESOLVE Managing Board met virtually to present work progress, discuss future steps and also evaluate the impact the COVID-19 pandemic is having on the project’s progr...
Half-time at Hypo-RESOLVE
Originally scheduled to take place in Wiesbaden, Germany, from 13-14 May 2020, the Hypo-RESOLVE Annual Progress Meeting 2020 had to be reorganised as a web meeting in face of the COVID-19 pandemic. Ow...
Effective Managing Board Meeting in Frankfurt/ Main
On 4th February 2020, the Managing Board of Hypo-RESOLVE met for its fifth face-to-face meeting at Frankfurt Airport. Besides presenting updates on their progress and first results from different Work...
Hypoglycaemia impacts all aspects of life, 24 hours a day
Paper on our work accepted by Diabetic Medicine
Work Package 2 “Studies addressing the mechanisms and consequences of hypoglycaemia“ gathering for a day full of science and personal interactions
An extremely successful Hypo-RESOLVE work package 2 (WP2) face-to-face meeting was held in Copenhagen on January 17 with representatives from almost all partners participating. The full day meeting st...
First Hypo-RESOLVE progress report
The Hypo-RESOLVE consortium is very pleased to announce that the EC accepted its 1st progress report covering the achievements of a very exciting first year. During the initial twelve months of the pr...
Hypo-RESOLVE database on track
Data upload completed for 71 out of >100 trials